Abstract
Inflammatory Bowel Disease (IBD) is a chronic disorder caused due to several factors. Out of these, inflammation is one of the major causative factors, and several inflammatory markers, like pro-inflammatory cytokines enzymes play an essential role in the progression and development of IBD. The existing therapies against IBD have severe adverse effects, and drug resistance can also occur. Hence, novel therapies against IBD need to be developed for the treatment and prevention of IBD. Natural products, specifically flavonoids, can be an excellent alternative to get better therapeutic efficacy. Hence, flavonoids can be utilized more bitterly as a drug candidate for IBD. Our review work mainly discussed the potential flavonoids and their role in treating IBD and also focussed on it by inhibiting inflammatory markers.

This publication has 64 references indexed in Scilit: